Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19.

Mendez, Sean R; Frank, Rachel C; Stevenson, Elizabeth K; Chung, Mabel; Silverman, Michael G

Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19.

Mendez, Sean R; Frank, Rachel C; Stevenson, Elizabeth K; Chung, Mabel; Silverman, Michael G.

Mendez SR; Department of Medicine, Massachusetts General Hospital, Boston, MA.
Frank RC; Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, MA.
Stevenson EK; Division of Pulmonary, Critical Care, and Sleep Medicine, North Shore Medical Center, Salem, MA.
Chung M; Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA; Heart Center Intensive Care Unit, Massachusetts General Hospital, Boston, MA; Smith Center for Outcomes Research in Cardiology, Division of Cardiovascular Medicine, Department of Medicine, Beth Isr
Silverman MG; Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, MA; Heart Center Intensive Care Unit, Massachusetts General Hospital, Boston, MA. Electronic address: mgsilverman@mgh.harvard.edu.

Chest ; 160(1): 89-93, 2021 07.

Article in English | MEDLINE | ID: covidwho-1131174

Subject(s)

COVID-19; Calcium Channel Blockers/therapeutic use; Dihydropyridines/therapeutic use; Hypertension/drug therapy; Hypoxia; Vasoconstriction/drug effects; Antihypertensive Agents/therapeutic use; COVID-19/diagnosis; COVID-19/epidemiology; COVID-19/physiopathology; COVID-19/therapy; Comorbidity; Correlation of Data; Female; Humans; Hypertension/epidemiology; Hypoxia/etiology; Hypoxia/physiopathology; Hypoxia/prevention & control; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2/isolation & purification; United States/epidemiology; Withholding Treatment/statistics & numerical data

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vasoconstriction / Dihydropyridines / Calcium Channel Blockers / COVID-19 / Hypertension / Hypoxia Type of study: Diagnostic study / Observational study / Prognostic study Limits: Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: Chest Year: 2021 Document Type: Article Affiliation country: J.chest.2021.01.073

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google